Google will recognise LegitScript Healthcare Certification for telemedicine providers in Spain from Aug. 5, 2026, LegitScript said today, opening paid search and display inventory to a category that had no compliant route onto the platform in the country. The change makes Spain the eleventh market where the certification functions as a gate on healthcare advertising.

The certification firm, headquartered in Portland, Oregon, described the arrangement as an expanded partnership with Google covering telemedicine businesses operating in the Spanish jurisdiction. Under the update, those businesses may apply for LegitScript Healthcare Certification and then promote their services across Google advertising platforms.

Eligibility to apply for LegitScript certification was never the constraint. Providers in Spain could already seek the credential. What changes on Aug. 5 is the platform side: according to LegitScript, Google's policy update marks the first time the certification will be recognised as part of Google's advertising approval process for providers in Spain.

That distinction matters commercially. A certification that no platform accepts produces no advertising access. The value of the credential in a given market is set almost entirely by whether the dominant search platform treats it as sufficient evidence of compliance.

What the certification requires

LegitScript's Healthcare Certification runs as a documented review rather than a self-attestation. According to the company, the process involves submitting an application, providing documentation to verify licensure and business legitimacy, and demonstrating adherence to patient privacy, clinical practices, and marketing integrity standards.

Those four review categories are the operative constraint for any Spanish provider weighing whether to pursue the credential. Licensure verification is the most objective of them. Patient privacy and clinical practice standards involve assessment against criteria that sit outside the advertising relationship altogether, which is precisely why platforms outsource the work.

Jaylene Kunze, Chief Operating and Financial Officer at LegitScript, framed the expansion in terms of the company's existing global footprint. "Through our partnership with Google, we're giving telemedicine providers around the world a safer path to online advertising," Kunze said. "Bringing our certification program to Spain advances our mission to help providers demonstrate compliance, advertise responsibly, and build trust with patients."

Angela Salter, Vice President of Enterprise Certification Sales and Partnerships at the company, addressed the demand side. "As global demand for telemedicine services ramps up, providers need safe avenues to reach patients online and advertise responsibly," Salter said. "Backed by our technology, proprietary data, and human expertise, LegitScript Certification allows providers to build credibility, connect with more patients through Google's ad platform, and navigate rapidly evolving healthcare regulations."

The market figure and its source

LegitScript cited a projected compound annual growth rate of 11.6% for the Spanish telehealth sector from 2026 to 2033, characterising Spain as an emerging key digital health market in Europe.

The figure carries a caveat worth stating plainly. It appears in a certification vendor's announcement of a product expansion into that same market, and the underlying research source is not identified in the press release. Growth projections extending seven years into a healthcare services category depend heavily on regulatory assumptions that no forecaster controls. Readers evaluating the Spanish opportunity should treat the number as the sponsor's framing rather than an independent measurement.

What the figure does establish is why Spain arrived on the list when it did. Certification programmes expand where the addressable base of paying applicants justifies the operational cost of building market-specific review criteria.

An eleventh market on a lengthening list

The press release positions the Spain move as following recent expansions in India and New Zealand, the United Kingdom, and Indonesia and the Philippines. LegitScript said certification is already required for telemedicine providers and online pharmacies using Google Ads in the United States, the United Kingdom, Canada, France, Australia, New Zealand, Indonesia, the Philippines, India and South Africa.

Spain becomes the eleventh entry on that list.

The sequence is legible from prior coverage. Google permitted LegitScript-certified telemedicine providers to promote services in France from Oct. 10, 2023, in what was then a narrow European opening. Australian online pharmacies and telemedicine providers came under the same certification requirement in 2024, with a 90-day grace period for existing advertisers and a seven-day warning before any suspension.

Japan added a dual pathway from January 2025, under which online pharmacies could qualify either through a valid pharmacy licence with active Ministry of Health, Labour and Welfare registration or through LegitScript certification. Canada's addiction treatment category was brought into the framework in February 2025, with LegitScript operating as the verification partner across Google, Meta and Microsoft.

The United Kingdom and Singapore followed in July 2025, after a June 25 announcement. Under that update, UK telemedicine services moved to an "Allowed with limitations" classification, with the policy stating that Google permits promotion of prescription drug services by providers certified through LegitScript's Healthcare Merchant Certification Program while barring promotion of prescription drugs in ads and landing pages.

Most recently, Google opened advertising to pharmacies in India and telemedicine providers in New Zealand in an April 8, 2026 announcement, with the platform policy update expected that same month. That coverage noted LegitScript reported a 103% increase in certified healthcare organisations over the preceding year, and that the firm holds recognition from Visa and Mastercard for card-not-present transaction assessment.

Why platforms outsource the review

The pattern across these markets is consistent, and it is not primarily about healthcare. It is about where liability for compliance assessment sits.

Google's healthcare advertising rules require the platform to distinguish a licensed telemedicine operation from an unlicensed one across dozens of jurisdictions with distinct licensing registries, prescribing rules and privacy statutes. Building that capability in-house for every market is a substantial fixed cost with no advertising revenue attached to it. Delegating the determination to a specialist creates a single interface the platform can apply uniformly.

The consequence for advertisers is a two-stage approval sequence. Certification first, platform certification second. In the India and New Zealand expansion, LegitScript-certified organisations became eligible to apply for Google certification once the platform policy updated - the credential functions as a prerequisite, not as approval in itself.

Google has been recalibrating the surrounding rules throughout the period. The platform launched restricted drug term certification for personalised pharmaceutical targeting in the United States, Canada and New Zealand in July 2025, applying it across Google Ads and Display & Video 360. It then deprecated the Restricted Medical Content label in August 2025, stating the change was intended to simplify internal enforcement for keyword-targeting enablement while preserving existing certification requirements.

In October 2025, Google revised prescription drug advertising rules for Canada, New Zealand and the United States, permitting promotional use of prescription drug terms in those three markets. Programmatic buyers received parallel treatment in January 2026, when an Authorized Buyers policy change removed the third-party verification layer for certain pharmaceutical categories.

The direction is not uniform loosening. Certification requirements expand in some categories while approval friction falls in others, and the two movements are largely independent.

Spain's existing position in Google's healthcare rules

Spain was not absent from Google's healthcare advertising framework before this update. The country gained permission for melatonin dietary supplement advertising alongside Germany and France in an October 2025 change, effective November 2025. That coverage noted Spain does not require pharmacy certification for dietary supplement advertising while maintaining restrictions on other product categories.

Spain also appeared among the nine markets eligible for personal lubricant advertising under the sexual health policy expansion announced Oct. 28, 2024 and effective Nov. 11, 2024. Prescription medications for erectile dysfunction and hypoactive sexual desire disorder under that same policy were confined to Canada, New Zealand and the United States.

The telemedicine gap was therefore specific rather than general. Spanish advertisers could reach consumers with certain regulated health products but had no recognised compliance route for promoting virtual consultation services.

What the announcement does not address

Several operational questions remain unresolved in the source material.

The press release does not specify a grace period for Spanish advertisers already running telemedicine campaigns, nor does it state whether the seven-day suspension warning applied in Australia and other markets extends to Spain. It does not disclose certification pricing, application processing times, or the volume of Spanish providers expected to qualify.

Nor does the announcement address prescription drug promotion. In the United Kingdom, Singapore, India and New Zealand implementations, direct promotion of prescription drugs in ad copy and landing pages remained prohibited even for certified providers. Whether Spain follows the same restriction is not stated in the materials LegitScript issued, and providers will need Google's published country-specific guidance to determine it.

What this means for the marketing community

For agencies handling Spanish healthcare accounts, the practical effect is a new billable compliance workstream with a fixed date attached. Certification cannot be completed retroactively, and campaigns cannot launch before the credential clears.

For the broader search market, the update extends a structural shift that has been building since 2023. Access to advertising inventory in regulated verticals increasingly depends on third-party credentials rather than platform review alone. The bottleneck moves from the ad account to the certifying organisation, and campaign timelines become dependent on an approval process the advertiser cannot escalate through platform support.

That dependency concentrates influence. A single private certifier now stands between telemedicine providers and Google's advertising inventory across eleven markets, with recognition from Visa, Mastercard, social platforms and marketplaces layered on top. No published data establishes how long Spanish applications will take to process or what proportion will be approved, which leaves the practical width of the new channel unknown until the first cohort clears review.

Spain's telehealth operators will find out from Aug. 5.

Timeline

Summary

Who: LegitScript, a Portland, Oregon merchant and product certification firm, and Google. The change affects telemedicine providers operating in Spain and the agencies handling their paid search and display campaigns.

What: Google will recognise LegitScript Healthcare Certification as part of its advertising approval process for telemedicine providers in Spain. Providers were already eligible to apply for the certification, but this is the first time Google has treated it as a qualifying credential for Spanish advertisers. The review covers licensure, business legitimacy, patient privacy, clinical practices and marketing integrity standards.

When: LegitScript announced the expansion today, July 23, 2026. The Google policy update takes effect on Aug. 5, 2026.

Where: Spain. The market joins the United States, the United Kingdom, Canada, France, Australia, New Zealand, Indonesia, the Philippines, India and South Africa, where LegitScript certification is already required for telemedicine providers and online pharmacies using Google Ads.

Why: LegitScript cited a projected 11.6% compound annual growth rate for the Spanish telehealth sector from 2026 to 2033, describing Spain as an emerging key digital health market in Europe. The figure comes from an interested party and no independent research source is identified in the announcement. For Google, third-party certification transfers the cost and liability of jurisdiction-specific compliance assessment away from the platform, which is the consistent structural logic behind every market added since France in 2023.